Amgen AMGN
NASDAQ AMGN
$432.52 -1.51 (-0.35%)
As of: Oct 16, 2026 · 3:59 PM EDT

Amgen (AMGN) Sales of Property, Plant and Equipment (2014 - 2016)

Updated

Amgen's Sales of Property, Plant and Equipment was $11 million in FY2017, down 85.9% from $78 million in FY2016.

Analysis

Amgen (AMGN) Sales of Property, Plant and Equipment (2014 - 2016) Analysis & Trends

From FY2013 onward, Amgen has reported Sales of Property, Plant and Equipment for 5 years.

  • Sales of Property, Plant and Equipment shows a four-year compound annual growth rate of -13.9% (FY2013 to FY2017).
  • The FY2017 figure marks the lowest annual Sales of Property, Plant and Equipment since FY2014.
  • Per Business Quant data, Sales of Property, Plant and Equipment in earlier years was $78 million in FY2016 (-71.5%), $274 million in FY2015, $3 million in FY2014 (-85.0%) and $20 million in FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn -
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 63.00 Mn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn -
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn -
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 26.00 Mn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 4.00 Mn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn -
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn -
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn -
10 Vertex Pharmaceuticals 126.70 Bn 98.70 Bn 2.84 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 63.00 Mn
Sep 30, 2016 1.00 Mn
Dec 31, 2015 3.00 Mn
Sep 30, 2015 45.00 Mn
Dec 31, 2014 3.00 Mn
API Access

Amgen Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=AMGN&period=max&api_key=YOUR_API_KEY